VeriMom¿Es disodium c12-14 sec-pareth-7 sulfosuccinate seguro durante el embarazo?
No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- ¿Es disodium c12-14 sec-pareth-7 sulfosuccinate seguro durante el embarazo?
- No harmonised CLP reproductive classifications found (ECHA Annex VI). No CIR or SCCS safety assessment flagging reproductive toxicity, and PubMed contains no credible reproductive/toxicology studies indicating teratogenicity or reproductive hazards for this specific sulfosuccinate; ECHA/PubChem entries list typical surfactant toxicology (irritation at high concentrations) but not reproductive endpoints. Topical cosmetic use would give low but measurable dermal exposure (surfactants have limited systemic absorption). Sources: ECHA Annex VI (no harmonised repro classification), PubChem, CosIng, PubMed (no reproductive studies found).
- ¿Es disodium c12-14 sec-pareth-7 sulfosuccinate seguro durante la lactancia?
- No data indicating reproductive or lactation toxicity or transfer into milk in ECHA/CIR/SCCS/PubMed sources. Mechanistic data for placental/milk transfer are absent. Dermal exposure in lactating persons is expected to be low but measurable; no evidence of systemic accumulation or endocrine activity that would raise concern. Sources: ECHA (registration/Cosing entries), PubChem, PubMed (no lactation studies).
- ¿Es disodium c12-14 sec-pareth-7 sulfosuccinate seguro para la piel del bebé?
- No infant-specific reproductive or developmental toxicity data were identified. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight ratio, exposure score is increased by +1 versus adults (adult e=1 → infant e=2). No evidence found for specific mechanisms (endocrine activity) or harmonised reproductive hazards. Sources: CosIng, ECHA registrations, PubChem, PubMed (no infant dermal absorption/reprotox studies).
- ¿Cómo puntúa VeriMom a disodium c12-14 sec-pareth-7 sulfosuccinate?
- VeriMom puntúa disodium c12-14 sec-pareth-7 sulfosuccinate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a disodium c12-14 sec-pareth-7 sulfosuccinate en el embarazo?
- Consulta nuestra lista de alternativas seguras a disodium c12-14 sec-pareth-7 sulfosuccinate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.